ovarian failure, chemotherapy, lymphoma, GnRH agonist
Showing 1 - 25 of >10,000
Premature Ovarian Failure Trial in Fayoum (Goserelin, Chemotherapy)
Enrolling by invitation
- Premature Ovarian Failure
-
Fayoum, Mesala, EgyptBeni Suef university
Dec 8, 2022
In Vitro Fertilization, ICSI Intracytoplasmic Spermatozoid Injection Trial in Bondy (Ovulation induction with hCG + Luteal phase
Not yet recruiting
- In Vitro Fertilization
- ICSI Intracytoplasmic Spermatozoid Injection
- Ovulation induction with hCG + Luteal phase support with vaginal progesterone
- Ovulation triggering by Triptorelin + Luteal phase support by Nafarelin
-
Bondy, FranceMaeliss Peigné
Nov 27, 2023
Ovarian Stimulation, Human Chorionic Gonadotropin, Oocyte Donors Trial in Thessaloniki (Dual trigger (human chorionic
Recruiting
- Ovarian Stimulation
- +2 more
- Dual trigger (human chorionic gonadotropin plus GnRH-agonist)
- GnRH-agonist only trigger
-
Thessaloniki, GreeceEmbryolab Fertility Clinic
Nov 20, 2023
Cancer, Toxicity Due to Chemo, Sarcoma Trial in Le Kremlin Bicêtre (Triptorelin (GnRHa) + Chemotherapy)
Unknown status
- Cancer
- +5 more
- Triptorelin (GnRHa) + Chemotherapy
-
Le Kremlin Bicêtre, FranceAP-HP, Bicêtre Hospital
Dec 16, 2019
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)
Not yet recruiting
- Breast Cancer
- Ovarian Function Suppression + Aromatase Inhibitor
- Adjuvant Chemotherapy + Ovarian Function Suppression
- (no location specified)
May 19, 2023
Female Infertility Trial in Alexandria (gonadotropin releasing hormone-agonist, Progesterone)
Recruiting
- Female Infertility
- gonadotropin releasing hormone-agonist
- Progesterone
-
Alexandria, EgyptAlexandria University
Apr 5, 2022
Breast Cancer Female, Acute Leukemia, Lymphoma Trial in Sweden (Triptorelin Embonate, Sodium Chloride solution 0.9%)
Not yet recruiting
- Breast Cancer Female
- +5 more
- Triptorelin Embonate
- Sodium Chloride solution 0.9%
-
Göteborg, Sweden
- +16 more
Oct 26, 2022
Endometriosis Trial (surveys (Fertiqol et SF36))
Not yet recruiting
- Endometriosis
- surveys (Fertiqol et SF36)
- (no location specified)
Oct 26, 2023
Fertility Trial in Barcelona (150µg CFA (Elonva®) at stimulation day (SD) 1 and 100µg CFA(Elonva®) at SD 5, 150µg CFA (Elonva®)
Not yet recruiting
- Fertility
- 150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5
- 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger
-
Barcelona, SpainHospital Universitario Quiron Dexeus
Nov 10, 2023
Infertility, Female Trial in Worldwide (FE 999049 + GnRH agonist (GONAPEPTYL), FE 999049 + GnRH antagonist (CETROTIDE))
Completed
- Infertility, Female
- FE 999049 + GnRH agonist (GONAPEPTYL)
- FE 999049 + GnRH antagonist (CETROTIDE)
-
Dobl, Austria
- +15 more
Sep 28, 2022
Cancer, Risk of Premature Ovarian Failure, Fertility Preservation Trial in New York (surgery to remove ovaries or high dose
Recruiting
- Cancer
- +2 more
- surgery to remove ovaries or high dose chemotherapy
-
New York, New YorkRonald O. Perelman and Claudia Cohen Center for Reproductive Med
Jan 18, 2023
Breast Tumor Malignant Female Trial in Belgium, France, Italy (Letrozole, standard-stimulated cohort)
Recruiting
- Breast Neoplasm Malignant Female
- Letrozole
- standard-stimulated cohort
-
Brussel, Belgium
- +5 more
Aug 2, 2022
Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure Trial in Tripoli (Human Chorionic
Unknown status
- Female Infertility
- +16 more
- Human Chorionic Gonadotropin (hCG)
- +3 more
-
Tripoli, North Lebanon, LebanonLebanese University, faculty of sciences III
Feb 21, 2021
Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility Trial (ultrashort GnRHa, short GnRHa, long GnRHa)
Not yet recruiting
- Intracytoplasmic Sperm Injection
- +3 more
- ultrashort GnRHa
- +2 more
- (no location specified)
Oct 2, 2022
Ovarian Reserve in Premenopausal Breast Cancer
Terminated
- Premenopausal Breast Cancer
- Breast Cancer
-
Dublin, Dublin 18, Ireland
- +9 more
Jan 14, 2022
Breast Cancer Female Trial in Leuven, Brussels (Triptorelin 3.75 MG Injection, Transvaginal oocyte retrieval, Triptorelin
Unknown status
- Breast Cancer Female
- Triptorelin 3.75 MG Injection
- +2 more
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Oct 29, 2020
Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln
Completed
- Lymphoma, Hodgkin
- +2 more
- Myo-Inositol and D-Chiro-Inositol (MIC)
-
Bari, ItalyIRCCS - Istituto Oncologico"Giovanni PaoloII"
Jun 2, 2022
Ovarian Hyperstimulation Syndrome, Infertility, Female Trial in Toronto (Pregnyl (1,500) IU, 1.5 mL of normal saline)
Recruiting
- Ovarian Hyperstimulation Syndrome
- Infertility, Female
- Pregnyl (1,500) IU
- 1.5 mL of normal saline
-
Toronto, Ontario, CanadaMount Sinai Hospital, Fertility Clinic
Dec 9, 2022
IVF, PCO Trial in Bani Suwayf (Dydrogesterone Tablets, Cetrorelix)
Not yet recruiting
- IVF
- PCO
- Dydrogesterone Tablets
- Cetrorelix
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 16, 2023
Infertility Trial in Giza (Double trigger, HCG trigger)
Not yet recruiting
- Infertility
- Double trigger
- HCG trigger
-
Giza, EgyptBedaya Hospital
Nov 23, 2023
IVF Trial in Bani Suwayf (Dydrogesterone, Cetrorelix acetate, Triptorelin)
Recruiting
- IVF
- Dydrogesterone
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Aug 1, 2023
Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer
Terminated
- Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
- +2 more
- Ribociclib
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 16, 2022
Endometriosis, Adenomyosis, Infertility, Female Trial in Suresnes (GnRH agonist)
Recruiting
- Endometriosis
- +2 more
- GnRH agonist
-
Suresnes, FranceHopital Foch
Aug 2, 2022